Soligenix Inc., formerly known as DOR BioPharma Inc., a late-stage biotechnology company, today announced it has formed a consortium to develop technology to enhance acting vaccines, including RiVax, the company’s proprietary vaccine for ricin toxin, which can be used as a biological weapon. Soligenix also announced it was awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to continue this work.

The announced consortium draws together industry and academic researchers from various disciplines, including the University of Colorado, the University of Kansas, and the Tulane National Primate Research Center, SRI International, Health Research Inc, Battelle Memorial Institute, Nanotherapeutics, and BioCon Inc.

“Each of our academic and industry consortium members brings impressive expertise to our vaccine stabilization program,” Dr. Robert N. Brey, PhD, chief scientific officer of Soligenix stated in the press release. “This association has the potential

...

University Endowment FundsUniversity Endowment Funds ListQuick Link: Hedge Fund Marketing GuideYesterday a hedge fund sent me this list of university endowments from Wikipedia and I thought I would share this with others involved in hedge fund marketing and sales.Institution Endowment (2005)billion USD Endowment (2006)billion USD Endowment (2007)billion USD Amherst College $ 1.155[1] $ 1.337[2] $ 1.662[3] ...